Unstoppable | A Conversation With Change Makers

On this episode of The Kara Goldin Show, we’re joined by Chris Moxham, CEO of Transcripta Bio, a biotech company revolutionizing drug discovery through the power of AI and transcriptomics. With a unique platform built on a vast perturbation atlas of small molecules, Transcripta is uncovering novel opportunities across a wide range of human diseases—faster and with more precision than traditional methods.In our conversation, Chris shares the story behind Transcripta Bio and how the team is building frontier AI models to predict biological responses from potential drug compounds. We dive into what makes their approach different, why a transcriptome-first strategy matters, and how they're unlocking insights that have the potential to lead to more targeted and effective therapies. Chris also speaks about the mindset required to lead in a rapidly evolving industry, the collaboration between AI and human expertise, and what’s next for the company.If you’re curious about the intersection of science and technology, t